Statements of Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Revenues
Expenses:
Research and development	(354,809)	(1,644,868)
General and administrative expenses	(911,581)	(3,749,867)
Total operating expenses	(1,266,390)	(5,394,735)
Loss from operations	(1,266,390)	(5,394,735)
Finance income (expense):
Finance expense	(307,516)	(750,462)	[1]
Net loss attributable to shareholders of the company	(1,573,906)	(6,145,197)	[1]
Net loss attributable to shareholders of preferred stock	(39,491)
Net loss used in the calculation of basic and diluted loss per share	$ (1,534,415)	$ (6,145,197)	[1]
Basic and diluted net loss per share	$ (0.07)	$ (0.32)	[1]
Weighted average shares outstanding - basic and diluted	21,780,899	18,966,032

[1] Restated - see Note 10.